Valuation Update With 7 Day Price Move • May 29
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩3,125, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 7x in the Tech industry in South Korea. Total loss to shareholders of 8.6% over the past three years. Valuation Update With 7 Day Price Move • May 11
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩3,735, the stock trades at a trailing P/E ratio of 10.5x. Average trailing P/E is 11x in the Tech industry in South Korea. Total returns to shareholders of 17% over the past three years. Annonce • Mar 13
BioSmart Co.,Ltd., Annual General Meeting, Mar 27, 2026 BioSmart Co.,Ltd., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 36-16, oncheon-daero 1122beon-gil, chungcheongnam-do, asan South Korea Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩4,360, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 12x in the Tech industry in South Korea. Total returns to shareholders of 20% over the past three years. New Risk • Feb 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩143.6b market cap, or US$99.1m). Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improves as stock rises 42% After last week's 42% share price gain to ₩5,680, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 10x in the Tech industry in South Korea. Total returns to shareholders of 50% over the past three years. New Risk • Dec 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.3% average weekly change). Market cap is less than US$100m (₩100.3b market cap, or US$68.5m). Valuation Update With 7 Day Price Move • Dec 15
Investor sentiment improves as stock rises 42% After last week's 42% share price gain to ₩3,970, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 11x in the Tech industry in South Korea. Total returns to shareholders of 8.2% over the past three years. New Risk • Aug 30
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2013 fiscal period end). Minor Risk Market cap is less than US$100m (₩74.9b market cap, or US$54.0m). New Risk • Apr 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.8% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.03% net profit margin). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (₩102.7b market cap, or US$72.2m). Reported Earnings • Mar 22
Full year 2024 earnings released: EPS: ₩6.00 (vs ₩915 in FY 2023) Full year 2024 results: EPS: ₩6.00 (down from ₩915 in FY 2023). Revenue: ₩484.3b (up 6.2% from FY 2023). Net income: ₩127.2m (down 99% from FY 2023). Profit margin: 0% (down from 3.9% in FY 2023). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Annonce • Mar 12
BioSmart Co.,Ltd., Annual General Meeting, Mar 26, 2025 BioSmart Co.,Ltd., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 36-16, oncheon-daero 1122beon-gil, chungcheongnam-do, asan South Korea New Risk • Dec 08
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2013 fiscal period end). Minor Risks Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (₩74.2b market cap, or US$52.1m). Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩4,205, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 9x in the Tech industry in South Korea. Total loss to shareholders of 21% over the past three years. Valuation Update With 7 Day Price Move • Aug 26
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩3,810, the stock trades at a trailing P/E ratio of 4.5x. Average trailing P/E is 9x in the Tech industry in South Korea. Total loss to shareholders of 42% over the past three years. Valuation Update With 7 Day Price Move • Jun 07
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩4,530, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 15x in the Tech industry in South Korea. Total loss to shareholders of 32% over the past three years. Annonce • Jun 06
An unknown buyer agreed to acquire a 13.33% stake in Tc Materials Co., Ltd. from BioSmart Co.,Ltd. (KOSDAQ:A038460) for KRW 10 billion An unknown buyer agreed to acquire a 13.33% stake in Tc Materials Co., Ltd. from BioSmart Co.,Ltd. (KOSDAQ:A038460) for KRW 10 billion on June 4, 2024. The transaction is expected to close on June 5, 2024. Valuation Update With 7 Day Price Move • May 20
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩6,560, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 10x in the Tech industry in South Korea. Total returns to shareholders of 6.0% over the past three years. Valuation Update With 7 Day Price Move • Apr 25
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩4,505, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 11x in the Tech industry in South Korea. Total loss to shareholders of 35% over the past three years. New Risk • Apr 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Earnings have declined by 17% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.9% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (7.0% increase in shares outstanding). Market cap is less than US$100m (₩109.1b market cap, or US$79.8m). Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩4,090, the stock trades at a trailing P/E ratio of 4.7x. Average trailing P/E is 12x in the Tech industry in South Korea. Total loss to shareholders of 31% over the past three years. Reported Earnings • Mar 23
Full year 2023 earnings released: EPS: ₩915 (vs ₩38.00 in FY 2022) Full year 2023 results: EPS: ₩915 (up from ₩38.00 in FY 2022). Revenue: ₩456.2b (up 16% from FY 2022). Net income: ₩17.9b (up ₩17.2b from FY 2022). Profit margin: 3.9% (up from 0.2% in FY 2022). Over the last 3 years on average, earnings per share has increased by 124% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Jan 19
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 12% to ₩3,370. The fair value is estimated to be ₩2,795, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 40% over the last 3 years. Earnings per share has grown by 87%. Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩3,720, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 12x in the Tech industry in South Korea. Total loss to shareholders of 65% over the past three years. New Risk • Oct 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.5x net interest cover). Earnings have declined by 31% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.2% average weekly change). Shareholders have been diluted in the past year (3.8% increase in shares outstanding). Market cap is less than US$100m (₩72.0b market cap, or US$53.6m). New Risk • Sep 01
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.5x net interest cover). Earnings have declined by 31% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.8% increase in shares outstanding). Market cap is less than US$100m (₩71.8b market cap, or US$54.2m). Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩3,070, the stock trades at a trailing P/E ratio of 54.3x. Average trailing P/E is 12x in the Tech industry in South Korea. Total loss to shareholders of 34% over the past three years. Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment improved over the past week After last week's 15% share price gain to ₩4,515, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 9x in the Tech industry in South Korea. Total loss to shareholders of 9.1% over the past three years. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩3,905, the stock trades at a trailing P/E ratio of 25.8x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 14% over the past three years. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Is New 90 Day High Low • Mar 04
New 90-day low: ₩6,140 The company is down 19% from its price of ₩7,600 on 04 December 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 20% over the same period. Is New 90 Day High Low • Jan 29
New 90-day low: ₩6,230 The company is down 37% from its price of ₩9,920 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 48% over the same period. Is New 90 Day High Low • Jan 08
New 90-day low: ₩7,280 The company is down 28% from its price of ₩10,100 on 08 October 2020. The South Korean market is up 25% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 39% over the same period. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩63.00 Per Share Will be paid on the 7th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.7% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (1.9%). Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improved over the past week After last week's 29% share price gain to ₩9,670, the stock is trading at a trailing P/E ratio of 58.2x, up from the previous P/E ratio of 45x. This compares to an average P/E of 24x in the Tech industry in South Korea. Total returns to shareholders over the past three years are 110%. Is New 90 Day High Low • Nov 25
New 90-day low: ₩8,150 The company is down 36% from its price of ₩12,800 on 27 August 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 22% over the same period. Valuation Update With 7 Day Price Move • Nov 09
Market bids up stock over the past week After last week's 20% share price gain to ₩11,650, the stock is trading at a trailing P/E ratio of 11.6x, up from the previous P/E ratio of 9.6x. This compares to an average P/E of 16x in the Tech industry in South Korea. Total returns to shareholders over the past three years are 131%. Valuation Update With 7 Day Price Move • Oct 27
Market bids up stock over the past week After last week's 19% share price gain to ₩10,750, the stock is trading at a trailing P/E ratio of 10.7x, up from the previous P/E ratio of 8.9x. This compares to an average P/E of 20x in the Tech industry in South Korea. Total returns to shareholders over the past three years are 118%.